Temple EEG raises $54M at $190M valuation — Steadview Capital and Peak XV (Sequoia India) back consumer EEG wearable
Summary
Temple raised $54 million at a $190 million post-money valuation, backed by Steadview Capital, Peak XV Partners (formerly Sequoia India & Southeast Asia), and Info Edge Ventures, as reported in Neurotech Notables #49 (February 2026). The consumer EEG wearable company targeting cognitive monitoring, sleep, and mental health applications is now one of the best-capitalized consumer EEG startups globally alongside Neurable ($65M) and Interaxon Muse. Peak XV's backing brings Sequoia's Southeast Asian and Indian network to a consumer EEG company — reflecting the large and growing Asian market for consumer neurotech products.
Why it matters
Peak XV (Sequoia India and Southeast Asia) investing in Temple with a $190M post-money valuation signals that Asian consumer markets are a primary target for consumer EEG wearables — not just the US and European markets where most consumer neurotech companies focus. India and Southeast Asia have massive young, tech-forward consumer populations with high smartphone penetration and growing mental health awareness, creating a commercial opportunity that US-centric consumer EEG companies routinely underestimate.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial